INB-BioTechnologies, Inc., a Wholly Owned Subsidiary of Integrated BioPharma, Inc., Announces the Membership of Its New Scientific Advisory Board

HILLSIDE, N.J., April 25, 2007 (PRIME NEWSWIRE) -- InB:Biotechnologies, Inc., a wholly owned subsidiary of Integrated BioPharma, Inc. (Nasdaq:INBP), today announced the membership of its new Scientific Advisory Board. The distinguished Board is supporting the Company's mission to develop and commercialize its innovative technology for plant-made biopharmaceuticals. The Scientific Advisory Board members have been selected for their expertise in the disciplines of vaccinology, immunology, plant molecular biology and clinical product development.